NCT00950105View on ClinicalTrials.gov

Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Crohn's Disease
Interventions
DRUG

CPSI-2364 or placebo

Single, oral dose of CPSI-2364 or placebo

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY